JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Battalion Oil
BATL
$58.4M
| $1.19M | ﹤0.01% |
+255,260
| New | +$1.52M |
2020 Q1
0 quarters
|
|
3152
Park National Corp
PRK
$3.25B
| $1.19M | ﹤0.01% |
15,332
+289
| +2% | +$26.9K |
2017 Q4
9 quarters
|
|
3153
Ironwood Pharmaceuticals
IRWD
$603M
| $1.19M | ﹤0.01% |
117,400
-14,645
| -11% | -$172K |
2014 Q3
22 quarters
|
|
|
NGD
3154
DELISTED
New Gold Inc
NGD
| $1.18M | ﹤0.01% |
2,316,828
-308,650
| -12% | -$250K |
2013 Q2
27 quarters
|
|
|
GRA
3155
DELISTED
W.R. Grace & Co.
GRA
| $1.18M | ﹤0.01% |
33,191
-40,682
| -55% | -$2.32M |
2013 Q2
27 quarters
|
|
3156
Bloom Energy
BE
$87.8B
| $1.18M | ﹤0.01% |
225,828
+37,681
| +20% | +$320K |
2018 Q3
6 quarters
|
|
|
CHS
3157
DELISTED
Chicos FAS, Inc.
CHS
| $1.18M | ﹤0.01% |
915,006
+579,611
| +173% | +$1.99M |
2013 Q2
27 quarters
|
|
3158
Harmonic Inc
HLIT
$1.23B
| $1.18M | ﹤0.01% |
204,148
+159,694
| +359% | +$1.07M |
2013 Q2
27 quarters
|
|
|
TBIO
3159
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.18M | ﹤0.01% |
117,855
+65,218
| +124% | +$534K |
2018 Q3
6 quarters
|
|
|
DO
3160
DELISTED
Diamond Offshore Drilling
DO
| $1.17M | ﹤0.01% |
640,629
-1,482,258
| -70% | -$6.06M |
2013 Q2
27 quarters
|
|
3161
Suzano
SUZ
$10.4B
| $1.17M | ﹤0.01% |
170,697
+170,337
| +47,316% | +$1.47M |
2019 Q1
4 quarters
|
|
3162
CALL
Biogen
BIIB
$33B
| $1.17M | ﹤0.01% |
3,700
-23,000
| -86% | -$6.98M |
2015 Q4
17 quarters
|
|
3163
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$531M
| $1.17M | ﹤0.01% |
22,636
-383
| -2% | -$20K |
2015 Q3
18 quarters
|
|
3164
Sierra Bancorp
BSRR
$515M
| $1.17M | ﹤0.01% |
66,401
+4,457
| +7% | +$108K |
2013 Q2
27 quarters
|
|
3165
Televisa
TV
$1.21B
| $1.17M | ﹤0.01% |
200,991
+170,332
| +556% | +$1.66M |
2013 Q2
27 quarters
|
|
|
CBAY
3166
DELISTED
Cymabay Therapeutics
CBAY
| $1.16M | ﹤0.01% |
786,408
+763,825
| +3,382% | +$1.28M |
2018 Q1
8 quarters
|
|
|
CNCE
3167
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.16M | ﹤0.01% |
131,717
-36,237
| -22% | -$357K |
2017 Q4
9 quarters
|
|
3168
GoDaddy
GDDY
$12.4B
| $1.16M | ﹤0.01% |
20,348
+839
| +4% | +$55.5K |
2015 Q2
19 quarters
|
|
3169
Superior Group of Companies
SGC
$209M
| $1.16M | ﹤0.01% |
137,252
+96,726
| +239% | +$1.13M |
2017 Q4
9 quarters
|
|
|
USDP
3170
DELISTED
USD PARTNERS LP
USDP
| $1.15M | ﹤0.01% |
398,709
+13,242
| +3% | +$109K |
2018 Q4
5 quarters
|
|
3171
PUT
Ingersoll Rand
IR
$30.8B
| $1.14M | ﹤0.01% |
+46,100
| New | +$1.46M |
2020 Q1
0 quarters
|
|
3172
CALL
Enterprise Products Partners
EPD
$80.5B
| $1.14M | ﹤0.01% |
79,800
-209,400
| -72% | -$4.86M |
2016 Q4
13 quarters
|
|
|
3173
PUT
Enterprise Products Partners
EPD
$80.5B
| $1.14M | ﹤0.01% |
79,800
| – | – |
2019 Q1
4 quarters
|
|
3174
CALL
Live Nation Entertainment
LYV
$40.1B
| $1.14M | ﹤0.01% |
+25,000
| New | +$1.54M |
2020 Q1
0 quarters
|
|
|
3175
PUT
Live Nation Entertainment
LYV
$40.1B
| $1.14M | ﹤0.01% |
+25,000
| New | +$1.54M |
2020 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.